Medicamen Biotech consolidated net profit declines 46.01% in the December 2023 quarter
Sales rise 30.69% to Rs 46.50 crore
Net profit of Medicamen Biotech declined 46.01% to Rs 2.03 crore in the quarter ended December 2023 as against Rs 3.76 crore during the previous quarter ended December 2022. Sales rose 30.69% to Rs 46.50 crore in the quarter ended December 2023 as against Rs 35.58 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales46.5035.58 31 OPM %10.5216.53 -PBDT5.085.82 -13 PBT3.274.22 -23 NP2.033.76 -46Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2024 | 5:15 PM IST